Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Health & Science

Recent news which mentions Health & Science

< Previous 1 2 3 4 5 6 7 8 9

...

Athenahealth to offer Abridge's AI scribe to its network of thousands of doctors

February 25, 2025

Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access

February 25, 2025

Hims & Hers shares tumble as margin miss adds to concerns about GLP-1 business

February 24, 2025

Chinese medical devices are in health systems across U.S., and the government and hospitals are worried

February 23, 2025

How the FDA's approval for food additives works, and why experts say a loophole allows companies to bypass it

February 23, 2025

Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million

February 21, 2025

Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker

February 21, 2025

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

February 21, 2025

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

February 21, 2025

UnitedHealth's rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months

February 21, 2025

Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall

February 20, 2025

From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs

February 20, 2025

Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s

February 19, 2025

UnitedHealthcare is offering buyouts to employees in benefits unit, could pursue layoffs, sources say

February 19, 2025

AI health-care startup OpenEvidence raises funding from Sequoia at $1 billion valuation

February 19, 2025

Hims & Hers to offer at-home blood draws and lab testing with new acquisition

February 19, 2025

High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models

February 18, 2025

Innovaccer launches AI agents for doctors and hospitals to address burnout

February 17, 2025

Moderna beats on revenue but loses more than expected as it scales down manufacturing

February 14, 2025

CVS shares are up 45% this year — here's why it may be starting to turn its business around

February 13, 2025

Prenuvo adds new health tests to flagship full-body scan, raises $120 million in fresh funding

February 13, 2025

U.S. investors, Big Pharma race to find new medicines in China

February 13, 2025

Healthy Returns: What to know about Trump's NIH funding cuts

February 12, 2025

CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices

February 12, 2025

Neuralink competitor Paradromics secures investment from Saudi Arabia's Neom

February 12, 2025

Apple launches first major health study in 5 years. Here's how you can opt in

February 12, 2025

Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short

February 12, 2025

CVS results top estimates even as high medical costs drag down insurance unit

February 12, 2025

Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma

February 10, 2025

Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad

February 07, 2025

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.